Liminal Biosciences Inc. (LMNL) Social Stream
LIMINAL BIOSCIENCES INC (LMNL) Price Targets From Analysts
Use the tables below to see what analysts covering LIMINAL BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-17 | 4 | $4.5 | $2.3 | $3.1 | $8.5 | -63.53% |
| 2022-03-21 | 2 | $2.3 | $2 | $2.15 | $8.5 | -74.71% |
| 2022-05-11 | 3 | $2.3 | $2 | $2.15 | $8.5 | -74.71% |
| 2022-07-25 | 2 | $2 | $0.12 | $1.06 | $8.5 | -87.53% |
| 2023-04-10 | 1 | $7.5 | $7.5 | $7.5 | $8.5 | -11.76% |
Price Target Last Issued April 10, 2023
The Trend in the Analyst Price Target
Over the past 19 months, LMNL's average price target has gone up $10.16.
LMNL reports an average of 58.11% for its upside potential over the past 0 secs.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-10 | 1 | 20.0 | 7.5 | 13.75 | 6.72 | 104.61% |
| 2023-04-10 | 1 | 7.5 | 7.5 | 7.50 | 6.72 | 11.61% |
LMNL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 13 months, LMNL's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LMNL as an investment opportunity.
- LMNL has a greater number of analysts covering the stock than 55.26% of all US stocks.
- LIMINAL BIOSCIENCES INC's average analyst price target is higher than 55.42% of all US stocks.
- LMNL has a greater upside potential (average analyst target price relative to current price) than 75.13% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, LIMINAL BIOSCIENCES INC's variance in analysts' estimates is lower than -535.3% of them.
In the Pharmaceutical Products industry, RAPT, TFFP, and APRE are the three stocks most similar to LIMINAL BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is LMNL a Buy, Hold or Sell? See the POWR Ratings now!